| P50 | author | Norman L. Letvin | Q98917684 |
| | James Mullins | Q57555076 |
| | David C. Montefiori | Q63302725 |
| P2093 | author name string | S Lu | |
| | E Johnson | |
| | K Manson | |
| | H L Robinson | |
| | J Arthos | |
| | J C Santoro | |
| | J R Haynes | |
| | F Mustafa | |
| | Y Yasutomi | |
| | M Wyand | |
| | J Wissink | |
| P2860 | cites work | DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations | Q24563751 |
| | Importance of the nef gene for maintenance of high virus loads and for development of AIDS | Q29618369 |
| | Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene | Q33196552 |
| | Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV | Q33395672 |
| | DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans | Q34209003 |
| | Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. | Q34214455 |
| | Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA | Q34302273 |
| | Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses | Q35793550 |
| | A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge. | Q35837607 |
| | Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. | Q35854152 |
| | Gene inoculation generates immune responses against human immunodeficiency virus type 1 | Q36284135 |
| | Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines | Q36630114 |
| | Passive immunization of macaques against SIV infection | Q72819547 |
| | Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques | Q67881585 |
| | The use of osmium-thiocarbohydrazide-osmium (OTO) and ferrocyanide-reduced osmium methods to enhance membrane contrast and preservation in cultured cells | Q70197884 |
| | Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA | Q70944351 |
| | Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection | Q71570061 |
| | Long-Term Anti-Nucleoprotein Cellular and Humoral Immunity Is Induced by Intramuscular Injection of Plasmid DNA Containing NP Gene | Q72100764 |
| | Titration and characterization of two rhesus-derived SIVmac challenge stocks | Q72489885 |
| | Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization | Q72548371 |
| | Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin | Q72603683 |
| | A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine | Q72625630 |
| | Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques | Q36631918 |
| | Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein | Q36632605 |
| | A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. | Q36636854 |
| | Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. | Q36640342 |
| | Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac | Q36653572 |
| | Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons | Q36655953 |
| | Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys | Q36683893 |
| | High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection | Q36729486 |
| | Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro | Q36797252 |
| | Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus | Q37375345 |
| | Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences | Q37577555 |
| | Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells | Q38334274 |
| | Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus | Q38948757 |
| | Complex determinants of macrophage tropism in env of simian immunodeficiency virus | Q39268981 |
| | Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. | Q40047174 |
| | Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells | Q40066880 |
| | Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay. | Q40191379 |
| | Pathogenic diversity of simian immunodeficiency viruses | Q40692683 |
| | Primate models for HIV vaccines. | Q40841881 |
| | Heterogeneity of HIV-1 and HIV-2. | Q41119972 |
| | HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. | Q41120023 |
| | Non-human primate models for AIDS vaccines. | Q41120027 |
| | Nucleic acid-based immunization against HIV-I: induction of protective in vivo immune responses. | Q41120035 |
| | Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. | Q41346392 |
| | Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. | Q41487464 |
| | Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251. | Q41490169 |
| | Efficacy of inactivated whole HIV-2 vaccines with various adjuvants in cynomolgus monkeys | Q41491959 |
| | Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160. | Q43632237 |
| | Heterologous protection against influenza by injection of DNA encoding a viral protein | Q43828996 |
| | Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus | Q43852663 |
| | Genetic immunization is a simple method for eliciting an immune response | Q43857336 |
| | Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine | Q44371143 |
| | Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. | Q44455932 |
| | Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. | Q44643645 |
| | DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates | Q45777945 |
| | Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. | Q45778258 |
| | Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network | Q45782916 |
| | Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. | Q45785662 |
| | Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys | Q45785779 |
| | Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes | Q45788144 |
| | Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus | Q45788449 |
| | Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism | Q45830933 |
| | Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins | Q45865515 |
| | Effect of dose and immunization schedule on immune response of baboons to recombinant glycoprotein 120 of HIV-1. | Q46211084 |
| | Prevention of HIV infection by passive immunization with HIV immunoglobulin | Q47571809 |
| | Vaccine protection against HIV-2 infection in cynomolgus monkeys | Q47573678 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Simian immunodeficiency virus | Q1890246 |
| | vaccine | Q134808 |
| P304 | page(s) | 3978-3991 | |
| P577 | publication date | 1996-06-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Simian immunodeficiency virus DNA vaccine trial in macaques | |
| P478 | volume | 70 | |